Origin Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Origin Asset Management's GILD Position: Q1 2017 in Review
Origin Asset Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 11,223 shares — an estimated $804K sold.
Origin Asset Management first reported a position in GILD in Q4 2013 and held it in 13 quarters. The position peaked at $42.7M in Q3 2014. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.
- Origin Asset Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
- Origin Asset Management sold 11,223 Gilead Sciences shares in Q1 2017, an estimated $804K.
- Origin Asset Management first reported a position in Gilead Sciences in Q4 2013 and held it in 13 quarters.
- Origin Asset Management's Gilead Sciences position peaked at $42.7M in Q3 2014.
- 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.
Based on Origin Asset Management's 13F filing for Q1 2017, filed 11 May 2017.